ABOUT
Dr. Manoj Gupta is European Board of Nuclear Medicine (FEBNM) Sweden and Asian Nuclear Medicine Board (FANMB) China certified specialist. He has the unique distinction of establishing the first PET CT in Sri Lanka.
He did his MBBS from UCMS, Delhi (2000 batch) and post graduation from renowned Institute in Nuclear Medicine, INMAS Delhi. He worked at RCGI&RC before moving to Sri Lanka for the above successful venture. He has presented his research work on PET CT in oncology in various national and international forums. He is a recipient of Asian Regional Cooperative Council of Nuclear Medicine (ARCCNM) young scientist grant awards continuously in 2009, 2010, 2012, 2013 and 2016.
He has published many research papers in both national and International peer reviewed journals. His keenness in the field of Nuclear Oncology has brought him back and he joined the institute as Consultant in June 2013.
PROFESSIONAL JOURNEY
ACHIEVEMENTS
Fellow European Board of Nuclear Medicine (FEBNM) Sweden.
Fellow Asian Nuclear Medicine Board (FANMB) China.
Established first PET-CT of Sri Lanka in ASIRI surgical Hospital, Colombo.
Credit to established protocol of PRRT and PRLT in the department.
Radiological Safety Officer II (Nuclear Medicine) Certificate by RPAD, BARC, 2012.
AWARDS
ARCCNM young scientist award for distinguished research in 2009, 2010, 2012, 2013 and 2016.
Best poster award in ARCCNM and SNMMI annual conference 2013, Mumbai, India.
PUBLICATIONS
Gupta M, Choudhury PS, Avinash Rao S,Mehta A. An original case of lip metastasis, from non small cell lung cancer. Hell J Nucl Med 2010;13:173-174.
Gupta M, Choudhary PS, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med 2014;29:38-39.
Gupta M,Choudhury PS, Nag S,Gupta P Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: A follow-up of 5 years or till recurrence. Hellinic Journal of Nuclear Medicine 2015;18:207-214.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels. Indian J Nucl Med 2015;30:16-20.
Gupta M, Choudhury PS, Dsouza M, Louis R, Datta A, Mishra A. 18F-FES PET-CT Scan turns out a problem solving modality in an ER positive metastatic breast cancer patient. American Journal of Cancer Case Reports 2015,3:215-220.
Chauhan D, Rawat S, Sharma MK, Ahlawat P, Pal M, Gupta G, Dewan A, Gupta M, et al. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas. J Can Res Ther 2015;11:746-51.
Gupta M, Choudhury PS, Gupta G, Gandhi J. Metastasis in urothelial carcinoma mimicking prostate cancer metastasis in Ga-68 prostate-specific membrane antigen positron emission tomography-computed tomography in a case of synchronous malignancy. Indian J Nucl Med 2016;31:222-4.
Gupta M, Datta A, Choudhury PS, Dsouza M, Batra U, Mishra A. Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptorpositive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?. World J Nucl Med 2017;16:133-9.
Gupta M, Choudhury P S, Hazarika D, Rawal S. A Comparative Study of 68Gallium-Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography and Magnetic Resonance Imaging for Lymph Node Staging in High Risk Prostate Cancer Patients: An Initial Experience. World J Nucl Med, July 2017 (In press).
